EPOCH: Eribulin and Pembrolizumab in Ovarian/Uterine Carcinosarcoma (EPOCH)
NCT 05619913 Brief Summary The EPOCH study population is patients with tubo-ovarian…
Read more arrow_forwardNCT 05619913 Brief Summary The EPOCH study population is patients with tubo-ovarian…
Read more arrow_forwardNCT 06554795 Brief Summary A Phase 1/2a First-in-Human Study of DB-1419 in…
Read more arrow_forwardNCT 06824155 Brief Summary This is a first-in-human, Phase 0/1, open-label study…
Read more arrow_forwardACTRN 12625000191493 Brief Summary This study is evaluating the safety and properties…
Read more arrow_forwardNCT 06349408 Brief Summary This is a Phase 1 multicenter, multi-regional, open-label,…
Read more arrow_forwardNCT 03486873 Brief Summary The purpose of this study is to evaluate…
Read more arrow_forwardNCT 06604533 Brief Summary The aim of this study is to investigate…
Read more arrow_forwardNCT 05735080 Brief Summary Incyclix Bio (Incyclix) is developing INX-315 as an…
Read more arrow_forwardACTRN 12623000959673 Brief Summary This study is evaluating the safety and properties…
Read more arrow_forwardNCT 06092580 Brief Summary The aims of this clinical trial are (1)…
Read more arrow_forward